Safety and tolerability of new-generation anti-obesity medications: a narrative review
The prevalence of obesity and associated comorbidities is rising. Despite their weight-loss efficacy, new generation anti-obesity medications are only prescribed to a minority of adults with obesity, possibly, which in part may be due to safety concerns. This review presents detailed safety profiles...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Revisão |
| Kieli: | englanti |
| Julkaistu: |
2018
|
| Linkit: | https://doi.org/10.1080/00325481.2018.1435129 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|